Citadel Advisors’s Neos Therapeutics, Inc NEOS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q1 | – | Hold |
0
| – | – | – | 7103 |
|
2020
Q4 | – | Sell |
-10,705
| Closed | -$6K | – | 5864 |
|
2020
Q3 | $6K | Buy |
+10,705
| New | +$6K | ﹤0.01% | 4593 |
|
2020
Q2 | – | Sell |
-34,271
| Closed | -$26K | – | 5573 |
|
2020
Q1 | $26K | Buy |
+34,271
| New | +$26K | ﹤0.01% | 4633 |
|
2019
Q3 | – | Sell |
-15,845
| Closed | -$20K | – | 5330 |
|
2019
Q2 | $20K | Sell |
15,845
-42,267
| -73% | -$53.4K | ﹤0.01% | 4501 |
|
2019
Q1 | $152K | Buy |
58,112
+29,878
| +106% | +$78.2K | ﹤0.01% | 4027 |
|
2018
Q4 | $47K | Sell |
28,234
-27,972
| -50% | -$46.6K | ﹤0.01% | 4114 |
|
2018
Q3 | $273K | Buy |
56,206
+28,908
| +106% | +$140K | ﹤0.01% | 3553 |
|
2018
Q2 | $171K | Buy |
+27,298
| New | +$171K | ﹤0.01% | 3728 |
|
2018
Q1 | – | Sell |
-10,730
| Closed | -$109K | – | 4579 |
|
2017
Q4 | $109K | Sell |
10,730
-56,712
| -84% | -$576K | ﹤0.01% | 3508 |
|
2017
Q3 | $617K | Buy |
+67,442
| New | +$617K | ﹤0.01% | 2571 |
|
2016
Q1 | – | Sell |
-26,087
| Closed | -$374K | – | 4188 |
|
2015
Q4 | $374K | Buy |
+26,087
| New | +$374K | ﹤0.01% | 2581 |
|